Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 34 (10), 1434-1439

One Decade Ago, One Decade Ahead in Huntington's Disease

Affiliations

One Decade Ago, One Decade Ahead in Huntington's Disease

Edward J Wild et al. Mov Disord.

Erratum in

  • Erratum.
    Mov Disord. 2020 Jan;35(1):199. doi: 10.1002/mds.27937. Epub 2019 Dec 4. Mov Disord. 2020. PMID: 31965633 No abstract available.

Abstract

No abstract available

Keywords: Huntington's disease; antisense therapy; huntingtin; neurodegeneration.

Similar articles

See all similar articles

References

    1. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993;72(6):971-983.
    1. Chang R, Liu X, Li S, Li X-J. Transgenic animal models for study of the pathogenesis of Huntington's disease and therapy. Drug design, development and therapy 2015;9:2179-2188.
    1. Wang Y, Steimle PA, Ren Y, et al. Dictyostelium huntingtin controls chemotaxis and cytokinesis through the regulation of myosin II phosphorylation. Mol Biol Cell 2011;22(13):2270-2281.
    1. Tartari M, Gissi C, Lo Sardo V, et al. Phylogenetic Comparison of Huntingtin Homologues Reveals the Appearance of a Primitive polyQ in Sea Urchin. Mol Biol Evol 2008;25(2):330-338.
    1. Nasir J, Floresco SB, O'Kusky JR, et al. Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell 1995;81(5):811-823.

Publication types

LinkOut - more resources

Feedback